Business Description
Allergy Therapeutics PLC
ISIN : GB00B02LCQ05
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.37 | |||||
Equity-to-Asset | 0.38 | |||||
Debt-to-Equity | 0.37 | |||||
Debt-to-EBITDA | -0.25 | |||||
Piotroski F-Score | 1/9 | |||||
Altman Z-Score | -2.39 | |||||
Beneish M-Score | -4.04 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -8.5 | |||||
3-Year Book Growth Rate | -64.8 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate | 58.67 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 11.38 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 43.93 | |||||
9-Day RSI | 44.41 | |||||
14-Day RSI | 44.23 | |||||
6-1 Month Momentum % | 92.45 | |||||
12-1 Month Momentum % | 209.09 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.4 | |||||
Quick Ratio | 0.93 | |||||
Cash Ratio | 0.54 | |||||
Days Inventory | 165.86 | |||||
Days Sales Outstanding | 54.82 | |||||
Days Payable | 185.21 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -2.6 | |||||
Shareholder Yield % | -27.19 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 52.54 | |||||
Operating Margin % | -72.92 | |||||
Net Margin % | -94.29 | |||||
FCF Margin % | -67.4 | |||||
ROE % | -226.59 | |||||
ROA % | -72.62 | |||||
ROIC % | -96.92 | |||||
3-Year ROIIC % | -4606.95 | |||||
ROC (Joel Greenblatt) % | -170.16 | |||||
ROCE % | -88.53 | |||||
Years of Profitability over Past 10-Year | 5 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 0.99 | |||||
PB Ratio | 6.75 | |||||
Price-to-Tangible-Book | 4.35 | |||||
EV-to-EBIT | -4.65 | |||||
EV-to-Forward-EBIT | -8.71 | |||||
EV-to-EBITDA | -5.15 | |||||
EV-to-Forward-EBITDA | -11.37 | |||||
EV-to-Revenue | 3.78 | |||||
EV-to-Forward-Revenue | 3.11 | |||||
EV-to-FCF | -5.28 | |||||
Price-to-Median-PS-Value | 0.21 | |||||
Earnings Yield (Greenblatt) % | -21.51 | |||||
FCF Yield % | -17.51 | |||||
Forward Rate of Return (Yacktman) % | -3.93 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Allergy Therapeutics PLC Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 61.911 | ||
EPS (TTM) (€) | -0.067 | ||
Beta | 8.68 | ||
Volatility % | 115.09 | ||
14-Day RSI | 44.23 | ||
14-Day ATR (€) | 0.003808 | ||
20-Day SMA (€) | 0.046025 | ||
12-1 Month Momentum % | 209.09 | ||
52-Week Range (€) | 0.0015 - 0.07 | ||
Shares Outstanding (Mil) | 4,766.44 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 1 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Allergy Therapeutics PLC Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Allergy Therapeutics PLC Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Allergy Therapeutics PLC Frequently Asked Questions
What is Allergy Therapeutics PLC(FRA:HHU)'s stock price today?
When is next earnings date of Allergy Therapeutics PLC(FRA:HHU)?
Does Allergy Therapeutics PLC(FRA:HHU) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |